Correlation Between Shanghai Commercial and Foresee Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shanghai Commercial and Foresee Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Commercial and Foresee Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shanghai Commercial Savings and Foresee Pharmaceuticals Co, you can compare the effects of market volatilities on Shanghai Commercial and Foresee Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Commercial with a short position of Foresee Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Commercial and Foresee Pharmaceuticals.

Diversification Opportunities for Shanghai Commercial and Foresee Pharmaceuticals

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Shanghai and Foresee is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Commercial Savings and Foresee Pharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foresee Pharmaceuticals and Shanghai Commercial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Commercial Savings are associated (or correlated) with Foresee Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foresee Pharmaceuticals has no effect on the direction of Shanghai Commercial i.e., Shanghai Commercial and Foresee Pharmaceuticals go up and down completely randomly.

Pair Corralation between Shanghai Commercial and Foresee Pharmaceuticals

Assuming the 90 days trading horizon Shanghai Commercial Savings is expected to generate 1.28 times more return on investment than Foresee Pharmaceuticals. However, Shanghai Commercial is 1.28 times more volatile than Foresee Pharmaceuticals Co. It trades about 0.24 of its potential returns per unit of risk. Foresee Pharmaceuticals Co is currently generating about -0.19 per unit of risk. If you would invest  3,720  in Shanghai Commercial Savings on September 26, 2024 and sell it today you would earn a total of  315.00  from holding Shanghai Commercial Savings or generate 8.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shanghai Commercial Savings  vs.  Foresee Pharmaceuticals Co

 Performance 
       Timeline  
Shanghai Commercial 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Commercial Savings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Shanghai Commercial is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Foresee Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Foresee Pharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Shanghai Commercial and Foresee Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shanghai Commercial and Foresee Pharmaceuticals

The main advantage of trading using opposite Shanghai Commercial and Foresee Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Commercial position performs unexpectedly, Foresee Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will offset losses from the drop in Foresee Pharmaceuticals' long position.
The idea behind Shanghai Commercial Savings and Foresee Pharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments